Immunogenicity and Safety of 13-Valent Pneumococcal Conjugate Vaccine in Infants and Toddlers (Q84791586)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20732948%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

title

Immunogenicity and safety of 13-valent pneumococcal conjugate vaccine in infants and toddlers (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20732948%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Immunogenicity and Safety of 13-Valent Pneumococcal Conjugate Vaccine in Infants and Toddlers (English)

1 reference

https://api.crossref.org/works/10.1542/PEDS.2009-3027

pneumococcal conjugate vaccine

21 June 2024

main subject

1 reference

1 reference

9

William C Gruber

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20732948%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

7

Kathrin U Jansen

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20732948%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

author name string

Alejandra Gurtman

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20732948%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Scott Patterson

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20732948%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Jack Love

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20732948%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

004 Study Group

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20732948%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Sylvia H. Yeh

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20732948

21 June 2024

David C. Hurley

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20732948

21 June 2024

Stan L. Block

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20732948

21 June 2024

Richard H. Schwartz

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20732948

21 June 2024

Kathrin U. Jansen

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20732948

21 June 2024

Emilio A. Emini

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20732948

21 June 2024

Daniel A. Scott

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20732948

21 June 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20732948

21 June 2024

publication date

23 August 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20732948%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20732948%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

volume

126

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20732948%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20732948%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

page(s)

e493-505

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20732948%20AND%20SRC:MED&resulttype=core&format=json

Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates

11 February 2020

cites work

1

1 reference

https://api.crossref.org/works/10.1542/PEDS.2009-3027

Changing epidemiology of invasive pneumococcal disease among older adults in the era of pediatric pneumococcal conjugate vaccine

21 June 2024

5

1 reference

https://api.crossref.org/works/10.1542/PEDS.2009-3027

Invasive pneumococcal disease among infants before and after introduction of pneumococcal conjugate vaccine

21 June 2024

6

1 reference

https://api.crossref.org/works/10.1542/PEDS.2009-3027

Indirect effect of 7-valent pneumococcal conjugate vaccine on pneumococcal colonization among unvaccinated household members

21 June 2024

7

1 reference

https://api.crossref.org/works/10.1542/PEDS.2009-3027

Serotype distribution of Streptococcus pneumoniae infections among preschool children in the United States, 1978-1994: implications for development of a conjugate vaccine

21 June 2024

8

1 reference

https://api.crossref.org/works/10.1542/PEDS.2009-3027

Serotype distribution and antimicrobial resistance patterns of Streptococcus pneumoniae isolated from children in China younger than 5 years

21 June 2024

11

1 reference

https://api.crossref.org/works/10.1542/PEDS.2009-3027

Emergence of Invasive Pneumococcal Disease Caused by Nonvaccine Serotypes in the Era of 7-Valent Conjugate Vaccine

21 June 2024

12

1 reference

https://api.crossref.org/works/10.1542/PEDS.2009-3027

Efficacy of pneumococcal conjugate vaccines in large scale field trials

21 June 2024

13

1 reference

https://api.crossref.org/works/10.1542/PEDS.2009-3027

Effectiveness of seven-valent pneumococcal conjugate vaccine against invasive pneumococcal disease: a matched case-control study

21 June 2024

14

1 reference

https://api.crossref.org/works/10.1542/PEDS.2009-3027

Effect of introduction of the pneumococcal conjugate vaccine on drug-resistant Streptococcus pneumoniae

21 June 2024

15

1 reference

https://api.crossref.org/works/10.1542/PEDS.2009-3027

Monitoring the impact of vaccines postlicensure: new challenges, new opportunities

21 June 2024

16

1 reference

https://api.crossref.org/works/10.1542/PEDS.2009-3027

Pneumococcal necrotizing pneumonia in Utah: does serotype matter?

21 June 2024

17

1 reference

https://api.crossref.org/works/10.1542/PEDS.2009-3027

An international serotype 3 clone causing pediatric noninvasive infections in Israel, Costa Rica, and Lithuania

21 June 2024

18

1 reference

https://api.crossref.org/works/10.1542/PEDS.2009-3027

Safety, tolerability, and immunologic noninferiority of a 13-valent pneumococcal conjugate vaccine compared to a 7-valent pneumococcal conjugate vaccine given with routine pediatric vaccinations in Germany

21 June 2024

19

1 reference

https://api.crossref.org/works/10.1542/PEDS.2009-3027

A multi-laboratory evaluation of an enzyme-linked immunoassay quantitating human antibodies to Streptococcus pneumoniae polysaccharides

21 June 2024

20

1 reference

https://api.crossref.org/works/10.1542/PEDS.2009-3027

Assignment of weight-based antibody units to a human antipneumococcal standard reference serum, lot 89-S

21 June 2024

21

1 reference

https://api.crossref.org/works/10.1542/PEDS.2009-3027

Estimating the protective concentration of anti-pneumococcal capsular polysaccharide antibodies

21 June 2024

23

1 reference

https://api.crossref.org/works/10.1542/PEDS.2009-3027

Approach to validating an opsonophagocytic assay for Streptococcus pneumoniae

21 June 2024

24

1 reference

https://api.crossref.org/works/10.1542/PEDS.2009-3027

Serological criteria for evaluation and licensure of new pneumococcal conjugate vaccine formulations for use in infants

21 June 2024

28

1 reference

https://api.crossref.org/works/10.1542/PEDS.2009-3027

Test-based exact confidence intervals for the difference of two binomial proportions

21 June 2024

29

1 reference

https://api.crossref.org/works/10.1542/PEDS.2009-3027

Safety and immunogenicity of a 13-valent pneumococcal conjugate vaccine

21 June 2024

30

1 reference

https://api.crossref.org/works/10.1542/PEDS.2009-3027

Decline in Invasive Pneumococcal Disease after the Introduction of Protein–Polysaccharide Conjugate Vaccine

21 June 2024

31

1 reference

https://api.crossref.org/works/10.1542/PEDS.2009-3027

Effect of prophylactic paracetamol administration at time of vaccination on febrile reactions and antibody responses in children: two open-label, randomised controlled trials.

21 June 2024

33

1 reference

https://api.crossref.org/works/10.1542/PEDS.2009-3027

Occurrence, distribution, and origins of Streptococcus pneumoniae Serotype 6C, a recently recognized serotype

21 June 2024

34

1 reference

https://api.crossref.org/works/10.1542/PEDS.2009-3027

Increase in the prevalence of the newly discovered pneumococcal serotype 6C in the nasopharynx after introduction of pneumococcal conjugate vaccine

21 June 2024

35

1 reference

https://api.crossref.org/works/10.1542/PEDS.2009-3027

Increase in serotype 6C pneumococcal carriage, United Kingdom.

21 June 2024

36

1 reference

https://api.crossref.org/works/10.1542/PEDS.2009-3027

PCR-based quantitation and clonal diversity of the current prevalent invasive serogroup 6 pneumococcal serotype, 6C, in the United States in 1999 and 2006 to 2007.

21 June 2024

37

1 reference

https://api.crossref.org/works/10.1542/PEDS.2009-3027

Differential effects of pneumococcal vaccines against serotypes 6A and 6C.

21 June 2024

38

1 reference

https://api.crossref.org/works/10.1542/PEDS.2009-3027

21 June 2024

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20732948%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

1 reference